Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Claret Capital Partners is a London-based investment firm that provides growth capital to innovative technology and life science companies across Europe. The firm manages the Claret European Growth Capital series of funds, which specialize in providing growth debt and equity to mid-to-late-stage businesses to fund expansion, acquisitions, or working capital. Within the healthcare and life sciences sectors, Claret targets companies with proven business models, including those in biotechnology, medical devices, and digital health. By offering flexible financing solutions, the firm helps scale companies that have already achieved significant clinical or commercial milestones. Claret acts as a strategic financial partner, often complementing traditional venture capital equity rounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claret European Growth Capital Fund.